SCHEMBL9762545

SCHEMBL9762545

CN(C)c1ccc2c([N+](=O)[O-])cccc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.65
▸ POLB P06746 2/20 0.51
▸ TXNRD1 Q16881 4/20 0.48
▸ TDP1 Q9NUW8 2/20 0.47
▸ NCF1 P14598 1/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NCOA1 Q15788 1/20 0.44
▸ NCOA3 Q9Y6Q9 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ CHRM3 P20309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4824287 0.84 ALDH1A1 (0.57) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL3955324 0.79 ALDH1A1 (1.00) ALDH1A1POLBTDP1SMN1; SMN2MAPT
SCHEMBL4816829 0.76 ALDH1A1 (0.67) ALDH1A1POLBTDP1NCF1SMN1; SMN2
SCHEMBL28286502 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL28044640 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL1200287 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL6272457 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL4818048 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1NCF1
SCHEMBL28252545 0.76 ALDH1A1 (0.66) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2
SCHEMBL4822352 0.75 ALDH1A1 (0.65) ALDH1A1POLBTXNRD1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 — — US disclosed
Send feedback